A Phase II Study of Photodynamic Therapy (PDT) With LEVULAN (RM) Topical Solution + Blue Light Versus LEVULAN (RM) Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities

Trial Profile

A Phase II Study of Photodynamic Therapy (PDT) With LEVULAN (RM) Topical Solution + Blue Light Versus LEVULAN (RM) Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2013

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Mar 2013 Results presented at the 71st Annual Meeting of the American Academy of Dermatology.
    • 01 Feb 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 02 Aug 2012 Treatment has been completed and DUSA Pharmaceuticals expects to report interim results before the end of the third quarter of 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top